Publications

  1. Rajput A, Ross JP, Bernales CQ, Rayaprolu S, Soto-Ortolaza AI, Ross OA, van Gerpen J, Uitti RJ, Wszolek ZK, Rajput AH, Vilarino-Guell C. VPS35 and DNAJC13 disease-causing variants in essential tremor. Eur J Hum Genet. 2014 Aug 13.
    View PubMed
  2. Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbe C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA. Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease. Neurobiol Aging. 2014 Aug; 35(8):1958.e1-2. Epub 2014 Mar 05.
    View PubMed
  3. Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzinska M, Momcilovic D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Mol Genet Genomic Med. 2014 May; 2(3):261-72. Epub 2014 Feb 11.
    View PubMed
  4. Ross JP, Rayaprolu S, Bernales CQ, Soto-Ortolaza AI, van Gerpen J, Uitti RJ, Wszolek ZK, Rajput A, Rajput AH, Rajput ML, Ross OA, Vilarino-Guell C. SLC1A2 rs3794087 does not associate with essential tremor. Neurobiol Aging. 2014 Apr; 35(4):935.e9-10. Epub 2013 Oct 16
    View PubMed
  5. Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. 2014 Feb; 127(2):271-82.
    View PubMed
  6. Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destee A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging. 2014 Jan; 35(1):266.e5-14. Epub 2013 Aug 17.
    View PubMed
  7. Labbe C, Rayaprolu S, Soto-Ortolaza A, Ogaki K, Uitti RJ, Wszolek ZK, Ross OA. Investigating FUS variation in Parkinson's disease. Parkinsonism Relat Disord. 2014 Jan; 20 Suppl 1:S147-9.
    View PubMed
  8. Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK. Update on novel familial forms of Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2014 Jan; 20 Suppl 1:S29-34.
    View PubMed
  9. Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK. Familial progressive supranuclear palsy: a literature review. Neurodegener. Dis. 2014; 13(2-3):180-2.
  10. Tolosa E, Litvan I, Hoglinger GU, Burn D, Lees A, Andres MV, Gomez-Carrillo B, Leon T, Del Ser T, Gomez JC, Tijero B, Berganzo K, Garcia de Yebenes J, Lopez Sendon JL, Garcia G, Tolosa E, Buongiorno MT, Bargalló N, Burguera JA, Martinez I, Ruiz-Martínez A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord. 2014; 29(4):470-8.
  11. Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK. Familial progressive supranuclear palsy: a literature review. Neurodegener Dis. 2014; 13(2-3):180-2. Epub 2013 Sep 24.
    View PubMed
  12. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013 Dec 3; 81(23):2032-8. Epub 2013 Nov 08.
    View PubMed
  13. Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Mov Disord. 2013 Oct; 28(12):1740-4. Epub 2013 Aug 02.
    View PubMed
  14. Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, Borjesson-Hanson A, Uitti RJ, Ross OA, Stoessl AJ, Rademakers R, Josephs KA, Dickson DW, Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord. 2013 Oct; 19(10):869-77. Epub 2013 Jun 17.
    View PubMed
  15. Labbe C, Soto-Ortolaza AI, Rayaprolu S, Harriott AM, Strongosky AJ, Uitti RJ, Van Gerpen JA, Wszolek ZK, Ross OA. Investigating the role of FUS exonic variants in essential tremor. Parkinsonism Relat Disord. 2013 Aug; 19(8):755-7. Epub 2013 Apr 16.
    View PubMed
  16. Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF, Boylan KB, Graff-Radford NR, Uitti RJ, Rademakers R, Wszolek ZK, Dickson DW. Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology. 2013 May 7; 80(19):1771-7. Epub 2013 Apr 17.
    View PubMed
  17. Rayaprolu S, Fujioka S, Traynor S, Soto-Ortolaza AI, Petrucelli L, Dickson DW, Rademakers R, Boylan KB, Graff-Radford NR, Uitti RJ, Wszolek ZK, Ross OA. TARDBP mutations in Parkinson's disease. Parkinsonism Relat Disord. 2013 Mar; 19(3):312-5. Epub 2012 Dec 08.
    View PubMed
  18. Dejesus-Hernandez M, Rayaprolu S, Soto-Ortolaza AI, Rutherford NJ, Heckman MG, Traynor S, Strongosky A, Graff-Radford N, Van Gerpen J, Uitti RJ, Shih JJ, Lin SC, Wszolek ZK, Rademakers R, Ross OA. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat Disord. 2013 Feb; 19(2):198-201. Epub 2012 Oct 18.
    View PubMed
  19. Soto-Ortolaza AI, Heckman MG, Labbe C, Serie DJ, Puschmann A, Rayaprolu S, Strongosky A, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Lynch T, Uitti RJ, Wszolek ZK, Ross OA. GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis. 2013; 2(4):287-99. Epub 2013 Nov 29.
    View PubMed
  20. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener. 2013; 8:19. Epub 2013 Jun 21.
    View PubMed
  21. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging. 2012 Dec; 33(12):2950.e5-7. Epub 2012 Jul 26.
    View PubMed
  22. Sharma M, Ioannidis JPA, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilarino-Guell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet. 2012 Nov; 49(11):721-6.
  23. Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilarino-Guell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology. 2012 Aug 14; 79(7):659-67. Epub 2012 Jul 11.
    View PubMed
  24. Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 2012 Aug 7; 79(6):566-74. Epub 2012 Jul 25.
    View PubMed
  25. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 1; 21(15):3500-12. Epub 2012 May 03.
    View PubMed
  26. Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, Volpicelli-Daley L, Romero N, Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med. 2012 Jul 4; 4(141):141ra90.
    View PubMed
  27. Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, Wang Y, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Zhang J. DJ-1 and alphaSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiol Aging. 2012 Apr; 33(4):836.e5-7. Epub 2011 Oct 21.
    View PubMed
  28. Xiao J, Uitti RJ, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK, Maraganore DM, Auburger G, Leube B, Lehnhoff K, LeDoux MS. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol. 2012 Apr; 71(4):458-69. Epub 2012 Mar 23.
    View PubMed
  29. Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol. 2012 Mar; 71(3):370-84.
    View PubMed
  30. Saunders-Pullman R, Raymond D, Stoessl AJ, Hobson D, Nakamura K, Pullman S, Lefton D, Okun MS, Uitti R, Sachdev R, Stanley K, San Luciano M, Hagenah J, Gatti R, Ozelius LJ, Bressman SB. Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology. 2012 Feb 28; 78(9):649-57. Epub 2012 Feb 15.
    View PubMed
  31. Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ. Loss of ability to work and ability to live independently in Parkinson's disease. Parkinsonism Relat Disord. 2012 Feb; 18(2):130-5. Epub 2011 Oct 04.
    View PubMed
  32. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cair Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012 Feb; 44(2):200-5. Epub 2011 Dec 25
    View PubMed
  33. Rutherford NJ, Finch NA, DeJesus-Hernandez M, Crook RJ, Lomen-Hoerth C, Wszolek ZK, Uitti RJ, Graff-Radford NR, Rademakers R. Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis. Neurobiol Aging. 2012 Feb; 33(2):424.e23-4. Epub 2010 Nov 12.
    View PubMed
  34. Aasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Kim HM, Leverenz JB, Ginghina C, Armaly J, Edwards KL, Snapinn KW, Stoessl AJ, Zhang J. Cerebrospinal fluid amyloid beta and tau in LRRK2 mutation carriers. Neurology. 2012 Jan 3; 78(1):55-61. Epub 2011 Dec 14.
    View PubMed
  35. Uitti RJ. Tandem deep brain stimulation--challenging new structural targets for Parkinson's disease. Parkinsonism Relat Disord. 2012 Jan; 18 Suppl 1:S171-3.
    View PubMed
  36. Uitti RJ. Treatment of Parkinson's disease: focus on quality of life issues. Parkinsonism Relat Disord. 2012 Jan; 18 Suppl 1:S34-6.
    View PubMed
  37. Sundal C, Fujioka S, Uitti RJ, Wszolek ZK. Autosomal dominant Parkinson's disease. Parkinsonism Relat Disord. 2012 Jan; 18 Suppl 1:S7-10.
    View PubMed
  38. Potts LF, Cambon AC, Ross OA, Rademakers R, Dickson DW, Uitti RJ, Wszolek ZK, Rai SN, Farrer MJ, Hein DW, Litvan I. Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study. BMC Med Genet. 2012; 13:16. Epub 2012 Mar 17.
    View PubMed
  39. Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener. 2012; 7:13. Epub 2012 Apr 11.
    View PubMed
  40. Heckman MG, Soto-Ortolaza AI, Diehl NN, Carrasquillo MM, Uitti RJ, Wszolek ZK, Graff-Radford NR, Ross OA. Evaluation of the role of SNCA variants in survival without neurological disease. PLoS One. 2012; 7(8):e42877. Epub 2012 Aug 13.
    View PubMed
  41. Wray S, Self M, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One. 2012; 7(8):e43099. Epub 2012 Aug 27.
    View PubMed
  42. Uitti RJ. Investigators contemplating such a study may also consider tracking neuropsychological outcome measures over time, as development of postural instability/falls and dementia represent the two most important predictors of survival and quality of life in patients with advancing Parkinson's disease. International Journal of Therapy and Rehabilitation. 2012; 19(2):96.
  43. Ross OA, Conneely KN, Wang T, Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Wszolek ZK, Uitti RJ, Louis ED, Clark LN, Farrer MJ, Testa CM. Genetic variants of alpha-synuclein are not associated with essential tremor. Mov Disord. 2011 Dec; 26(14):2552-6. Epub 2011 Oct 24.
    View PubMed
  44. Sharma M, Maraganore DM, Ioannidis JP, Riess O, Aasly JO, Annesi G, Abahuni N, Bentivoglio AR, Brice A, Van Broeckhoven C, Chartier-Harlin MC, Destee A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Gispert S, Hattori N, Jasinska-Myga B, Klein C, Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiol Aging. 2011 Nov; 32(11):2108.e1-5. Epub 2011 Jul 22.
    View PubMed
  45. Kouri N, Murray ME, Hassan A, Rademakers R, Uitti RJ, Boeve BF, Graff-Radford NR, Wszolek ZK, Litvan I, Josephs KA, Dickson DW. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain. 2011 Nov; 134(Pt 11):3264-75. Epub 2011 Sep 20.
    View PubMed
  46. Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol. 2011 Oct; 10(10):898-908. Epub 2011 Aug 30.
    View PubMed
  47. Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, Lincoln SJ, Lepretre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet. 2011 Sep 9; 89(3):398-406.
    View PubMed
  48. Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011 Aug 30; 77(9):875-82. Epub 2011 Aug 17.
    View PubMed
  49. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011 Aug 15; 20(16):3207-12. Epub 2011 May 24.
    View PubMed
  50. Dachsel JC, Wider C, Vilarino-Guell C, Aasly JO, Rajput A, Rajput AH, Lynch T, Craig D, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Heckman MG, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Death-associated protein kinase 1 variation and Parkinson's disease. Eur J Neurol. 2011 Aug; 18(8):1090-3. Epub 2010 Nov 30.
    View PubMed
  51. Vilarino-Guell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011 Jul 15; 89(1):162-7.
    View PubMed
  52. Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jul; 43(7):699-705. Epub 2011 Jun 19.
    View PubMed
  53. Puschmann A, Verbeeck C, Heckman MG, Soto-Ortolaza AI, Lynch T, Jasinska-Myga B, Opala G, Krygowska-Wajs A, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA. Human leukocyte antigen variation and Parkinson's disease. Parkinsonism Relat Disord. 2011 Jun; 17(5):376-8. Epub 2011 Apr 11.
    View PubMed
  54. Spector AR, Dugger BN, Wszolek ZK, Uitti RJ, Fredrickson P, Kaplan J, Boeve BF, Dickson DW, Strongosky A, Lin SC. Anatomy of disturbed sleep in pallido-ponto-nigral degeneration. Ann Neurol. 2011 Jun; 69(6):1014-25.
    View PubMed
  55. Wider C, Vilarino-Guell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. Eur J Neurol. 2011 Jun; 18(6):876-81. Epub 2010 Dec 15.
    View PubMed
  56. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011 May; 69(5):778-92. Epub 2011 Mar 09.
    View PubMed
  57. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzinska M, Pfeiffer RF, Le C, LeDoux MS. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord. 2011 Feb 15; 26(3):549-52. Epub 2011 Mar 02.
    View PubMed
  58. Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology. 2011 Feb 15; 76(7):670-2.
    View PubMed
  59. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011 Feb 1; 76(5):467-74. Epub 2010 Dec 22.
    View PubMed
  60. Stomal-Slowinska M, Slowinski J, Lee TK, Uitti RJ, Deen HG, Reimer R, Cheshire WP Jr, Herzog-Bryan G, Wharen RE Jr. Correlation of clinical findings and results of percutaneous balloon compression for patients with trigeminal neuralgia. Clin Neurol Neurosurg. 2011 Jan; 113(1):14-21.
    View PubMed
  61. Behrouz B, Vilarino-Guell C, Heckman MG, Soto-Ortolaza AI, Aasly JO, Sando S, Lynch T, Craig D, Uitti RJ, Wszolek ZK, Ross OA, Farrer MJ. Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease. Neurosci Lett. 2010 Dec 17; 486(3):228-30. Epub 2010 Sep 29.
    View PubMed
  62. Vilarino-Guell C, Ross OA, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Lee MC, Hentati F, Uitti RJ, Wszolek ZK, Farrer MJ, Wu RM. An independent replication of PARK16 in Asian samples. Neurology. 2010 Dec 14; 75(24):2248-9.
    View PubMed
  63. Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010 Oct; 11(4):401-8. Epub 2010 Apr 06.
    View PubMed
  64. Ahlskog JE, Uitti RJ. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? Neurology. 2010 Apr 6; 74(14):1143-8.
    View PubMed
  65. Wider C, Vilarino-Guell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Association of the MAPT locus with Parkinson's disease. Eur J Neurol. 2010 Mar; 17(3):483-6. Epub 2009 Nov 12.
    View PubMed
  66. Soto-Ortolaza AI, Behrouz B, Wider C, Vilarino-Guell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Calbindin-1 association and Parkinson's disease. Eur J Neurol. 2010 Feb; 17(2):208-11. Epub 2009 Aug 5.
    View PubMed
  67. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord. 2010 Feb; 16(2):109-11. Epub 2009 Aug 31.
    View PubMed
  68. Keeling BH, Vilarino-Guell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, Wszolek ZK, Farrer MJ. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor. Parkinsonism Relat Disord. 2010 Feb; 16(2):112-4. Epub 2009 Sep 20.
    View PubMed
  69. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS. Novel THAP1 sequence variants in primary dystonia. Neurology. 2010 Jan 19; 74(3):229-38.
    View PubMed
  70. Jasinska-Myga B, Putzke JD, Wider C, Wszolek ZK, Uitti RJ. Depression in Parkinson's disease. Can J Neurol Sci. 2010 Jan; 37(1):61-6.
    View PubMed
  71. Uitti RJ. Parkinson's disease and issues related to driving. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S122-5.
    View PubMed
  72. Cobb SA, Wider C, Ross OA, Mata IF, Adler CH, Rajput A, Rajput AH, Wu RM, Hauser R, Josephs KA, Carr J, Gwinn K, Heckman MG, Aasly JO, Lynch T, Uitti RJ, Wszolek ZK, Kapatos G, Farrer MJ. GCH1 in early-onset Parkinson's disease. Mov Disord. 2009 Oct 30; 24(14):2070-5.
    View PubMed
  73. Keeling BH, Vilarino-Guell C, Ross OA, Wszolek ZK, Uitti RJ, Farrer MJ. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci Lett. 2009 Sep 18; 461(2):74-5. Epub 2009 Jun 12.
    View PubMed
  74. Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease. Eur J Neurol. 2009 Aug; 16(8):909-11. Epub 2009 Mar 31.
    View PubMed
  75. Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J. Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat Disord. 2009 Aug; 15(7):539-41. Epub 2008 Nov 28.
    View PubMed
  76. Vilarino-Guell C, Chai H, Keeling BH, Young JE, Rajput A, Lynch T, Aasly JO, Uitti RJ, Wszolek ZK, Farrer MJ, Lin SC. MEIS1 p.R272H in familial restless legs syndrome. Neurology. 2009 Jul 21; 73(3):243-5.
    View PubMed
  77. Vilarino-Guell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Destee A, Characterization of DCTN1 genetic variability in neurodegeneration. Neurology. 2009 Jun 9; 72(23):2024-8.
    View PubMed
  78. Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Phactr2 and Parkinson's disease. Neurosci Lett. 2009 Mar 27; 453(1):9-11. Epub 2009 Feb 10.
    View PubMed
  79. Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A, FIRST-STEP Study Group. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease. Mov Disord. 2009 Mar 15; 24(4):541-50.
    View PubMed
  80. Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Fine-mapping and candidate gene investigation within the PARK10 locus. Eur J Hum Genet. 2009 Mar; 17(3):336-43. Epub 2008 Oct 15.
    View PubMed
  81. Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov Disord. 2009 Feb 15; 24(3):455-9.
    View PubMed
  82. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet. 2008 Dec 1; 17(23):3631-42. Epub 2008 Aug 21.
    View PubMed
  83. Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T, Parkinson's Study Group-PROGENI Investigators. Clinical correlates of depressive symptoms in familial Parkinson's disease. Mov Disord. 2008 Nov 15; 23(15):2216-23.
    View PubMed
  84. Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilarino-Guell C, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Parkinsonism Relat Disord. 2008 Nov; 14(7):544-7. Epub 2008 Aug 22.
    View PubMed
  85. Ross OA, Soto AI, Vilarino-Guell C, Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord. 2008 Nov; 14(7):539-43. Epub 2008 Sep 14.
    View PubMed
  86. Obwegeser AA, Uitti RJ, Lucas JA, Witte RJ, Turk MF, Galiano K, Wharen RE. Correlation of outcome to neurosurgical lesions: confirmation of a new method using data after microelectrode-guided pallidotomy. Br J Neurosurg. 2008 Oct; 22(5):654-62.
    View PubMed
  87. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol. 2008 Aug; 65(8):1074-80.
    View PubMed
  88. Vilarino-Guell C, Soto AI, Young JE, Lin SC, Uitti RJ, Wszolek ZK, Farrer MJ. Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology. 2008 Jul 15; 71(3):222-3.
    View PubMed
  89. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol. 2008 Jul; 67(7):649-56.
    View PubMed
  90. Wider C, Uitti RJ, Wszolek ZK, Fang JY, Josephs KA, Baker MC, Rademakers R, Hutton ML, Dickson DW. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov Disord. 2008 Jun 15; 23(8):1168-73.
    View PubMed
  91. Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, De Deyn PP, Engelborghs S, Pickut B, Uitti Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology. 2008 Apr 15; 70(16 Pt 2):1456-60. Epub 2008 Mar 12.
    View PubMed
  92. Imamura A, Geda YE, Slowinski J, Wszolek ZK, Brown LA, Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol. 2008 Apr; 15(4):350-4. Epub 2008 Feb 26.
    View PubMed
  93. Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol. 2008 Jan; 255(1):37-44. Epub 2007 Dec 19.
    View PubMed
  94. Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology. 2007 Oct 9; 69(15):1480-90. Epub 2007 Sep 19.
    View PubMed
  95. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord. 2007 Oct; 13(7):386-8. Epub 2007 Apr 02.
    View PubMed
  96. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: Phenotypic expression in a clinical cohort. Parkinsonism Relat Disord. 2007 Aug; 13(6):333-9. Epub 2007 Feb 08.
    View PubMed
  97. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm. 2007 Jul; 114(7):947-50. Epub 2007 Feb 23.
    View PubMed
  98. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord. 2007 May; 13(4):230-9. Epub 2006 Dec 29.
    View PubMed
  99. Slowinski JL, Putzke JD, Uitti RJ, Lucas JA, Turk MF, Kall BA, Wharen RE. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg. 2007 Apr; 106(4):626-32.
    View PubMed
  100. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr; 80(4):769-78. Epub 2007 Mar 08.
    View PubMed
  101. Baba Y, Uitti RJ, Boylan KB, Uehara Y, Yamada T, Farrer MJ, Couchon E, Batish SD, Wszolek ZK. Aprataxin (APTX) gene mutations resembling multiple system atrophy. Parkinsonism Relat Disord. 2007 Apr; 13(3):139-42. Epub 2006 Oct 27.
    View PubMed
  102. Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ. ELAVL4, PARK10, and the Celts. Mov Disord. 2007 Mar 15; 22(4):585-7.
    View PubMed
  103. Slowinski J, Dominik J, Uitti RJ, Ahmed Z, Dickson DD, Wszolek ZK. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology. 2007 Feb; 27(1):73-80.
    View PubMed
  104. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol. 2007 Feb; 66(2):142-51.
    View PubMed
  105. Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Parkinson Study Group - PROGENI Investigators. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation. Mov Disord. 2007 Jan 15; 22(2):254-7.
    View PubMed
  106. NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 2007 Jan 2; 68(1):20-8.
    View PubMed
  107. Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006 Dec; 20(4):623-36.
    View PubMed
  108. Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group-PROGENI Investigators. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2257-60.
    View PubMed
  109. Imamura A, Uitti RJ, Wszolek ZK. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord. 2006 Dec; 12(8):506-8. Epub 2006 May 24.
    View PubMed
  110. Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry. 2006 Nov; 77(11):1235-7.
    View PubMed
  111. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006 Oct 15; 15(20):2988-3001. Epub 2006 Sep 01.
    View PubMed
  112. Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Durr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol. 2006 Sep; 63(9):1250-4.
    View PubMed
  113. Wszolek ZK, Baba Y, Mackenzie IR, Uitti RJ, Strongosky AJ, Broderick DF, Baker MC, Melquist S, Hutton ML, Tsuboi Y, Allanson JE, Carr J, Kumar A, Calne SM, Miklossy J, McGeer PL, Calne DB, Stoessl AJ. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology. 2006 Aug 22; 67(4):620-5.
    View PubMed
  114. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R, Poewe W, Troster AI, Uitti R, Voon V. Deep brain stimulation: preoperative issues. Mov Disord. 2006 Jun; 21 Suppl 14:S171-96.
    View PubMed
  115. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort. Mov Disord. 2006 May; 21(5):689-92.
    View PubMed
  116. Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, Uitti RJ, Fujino Y, Boeve BF, Hutton ML, Baker MC, Dickson DW. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol. 2006 Apr; 65(4):396-405.
    View PubMed
  117. Baba Y, Markopoulou K, Putzke JD, Whaley NR, Farrer MJ, Wszolek ZK, Uitti RJ. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol. 2006 Apr; 63(4):579-83.
    View PubMed
  118. Baba Y, Ghetti B, Baker MC, Uitti RJ, Hutton ML, Yamaguchi K, Bird T, Lin W, DeLucia MW, Dickson DW, Wszolek ZK. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol. 2006 Apr; 111(4):300-11. Epub 2006 Mar 08.
    View PubMed
  119. NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006 Mar 14; 66(5):664-71. Epub 2006 Feb 15.
    View PubMed
  120. Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet. 2006 Mar; 14(3):322-31.
    View PubMed
  121. Uchikado H, DelleDonne A, Uitti R, Dickson DW. Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol. 2006 Feb; 111(2):186-92. Epub 2006 Feb 03.
    View PubMed
  122. Mata IF, Bodkin CL, Adler CH, Lin SC, Uitti RJ, Farrer MJ, Wszolek ZK. Genetics of restless legs syndrome. Parkinsonism Relat Disord. 2006 Jan; 12(1):1-7.
    View PubMed
  123. Pankgratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Foroud T, Nichols WC, the Parkinson Study Group PROGENI Investigators (Uitti RJ). Mutation in DJ-1 are rate in familial Parkinson disease. Neuroscience Letters. 2006; 408(3):209-13.
  124. Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl. 2006(70):221-9.
    View PubMed
  125. Uitti RJ, Wszolek ZK. Concerning neuroprotective therapy for Parkinson's disease. J Neural Transm Suppl. 2006; (70):433-7.
    View PubMed
  126. Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain. 2005 Dec; 128(Pt 12):2777-85. Epub 2005 Aug 04.
    View PubMed
  127. Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord. 2005 Dec; 11(8):493-8. Epub 2005 Sep 09.
    View PubMed
  128. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson's disease phenotype. J Neurol. 2005 Oct; 252(10):1201-5. Epub 2005 Sep 12.
    View PubMed
  129. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005 Aug; 20(8):982-8.
    View PubMed
  130. Baba Y, Uitti RJ. Fragile X-associated tremor/ataxia syndrome and movements disorders. Curr Opin Neurol. 2005 Aug; 18(4):393-8.
    View PubMed
  131. Wharen RE Jr, Putzke JD, Uitti RJ. Deep brain stimulation lead fixation: a comparative study of the Navigus and Medtronic burr hole fixation device. Clin Neurol Neurosurg. 2005 Aug; 107(5):393-5. Epub 2004 Dec 15.
    View PubMed
  132. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease: handedness predicts asymmetry. Neurology. 2005 Jun 14; 64(11):1925-30.
    View PubMed
  133. Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, Farrer M, Putzke JD, Woodruff BK, Ghetti B, Murrell JR, Boeve BF, Petersen RC, Verpillat P, Brice A, Delisle MB, Rascol O, Arima K, Dysken MW, Yasuda M, Kobayashi T, Sunohara N, Komure O, Kuno The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord. 2005 Jun; 11(4):205-8.
    View PubMed
  134. Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc. 2005 May; 80(5):641-51.
    View PubMed
  135. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord. 2005 May; 11(3):139-45.
    View PubMed
  136. Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord. 2005 May; 11(3):147-50.
    View PubMed
  137. Putzke JD, Uitti RJ, Obwegeser AA, Wszolek ZK, Wharen RE. Bilateral thalamic deep brain stimulation: midline tremor control. J Neurol Neurosurg Psychiatry. 2005 May; 76(5):684-90.
    View PubMed
  138. Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ. Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord. 2005 Feb; 20(2):230-3.
    View PubMed
  139. Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T, Parkinson Study Group-PROGENI investigators. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet. 2005 Jan 29-Feb 4; 365(9457):410-2.
    View PubMed
  140. Ondo WG, Bronte-Stewart H, DBS Study Group. The North American survey of placement and adjustment strategies for deep brain stimulation. Stereotact Funct Neurosurg. 2005; 83(4):142-7. Epub 2005 Oct 3.
    View PubMed
  141. Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder. Parkinsonism Relat Disord. 2004 Dec; 10(8):461-3.
    View PubMed
  142. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004 Nov 18; 44(4):601-7.
    View PubMed
  143. Putzke JD, Wharen RE, Obwegeser AA, Wszolek ZK, Lucas JA, Turk MF, Uitti RJ. Thalamic deep brain stimulation for essential tremor: Recommendations for long-term outcome analysis. Can J Neurol Sci. 2004 Aug; 31(3):333-42.
    View PubMed
  144. Nichols WC, Uniacke SK, Pankratz N, Reed T, Simon DK, Halter C, Rudolph A, Shults CW, Conneally PM, Foroud T, Parkinson Study Group. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease. Mov Disord. 2004 Jun; 19(6):649-55.
    View PubMed
  145. Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Muller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology. 2004 May 11; 62(9):1619-22.
    View PubMed
  146. Pankratz N, Uniacke SK, Halter CA, Rudolph A, Shults CW, Conneally PM, Foroud T, Nichols WC, Parkinson Study Group. Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci. Neurology. 2004 May 11; 62(9):1616-8.
    View PubMed
  147. Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet. 2004 Jan; 74(1):11-9. Epub 2003 Dec 19.
    View PubMed
  148. Parkinson Study Group(Uitti RJ). Levodopa and the rate of progression of Parkinson disease, the ELLDOPA study. N Engl J Med. 2004; 351:2498-508.
  149. Parkinson Study Group (Uitti RJ). The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD. Neurology. 2004; 62(2):330-2.
  150. Putzke JD, Wharen RE Jr, Wszolek ZK, Turk MF, Strongosky AJ, Uitti RJ. Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. Parkinsonism Relat Disord. 2003 Dec; 10(2):81-8.
    View PubMed
  151. Furtado S, Pfeiffer RF, Uitti RJ, Wszolek ZK. Neurotherapeutics and movement disorders. World Federation of Neurology. 2003 Nov 9.
    View PubMed
  152. Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A, Shults CW, Conneally PM, Foroud T, Parkinson Study Group. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet. 2003 Oct 15; 12(20):2599-608. Epub 2003 Aug 12.
    View PubMed
  153. Slowinski J, Wharen RE, Uitti RJ, Wszolek ZK, Krygowska-Wajs A, Mrowka R. [Current therapies for parkinson's disease. Part II: surgical treatment]. Neurol Neurochir Pol. 2003 May-Jun; 37(3):677-86.
    View PubMed
  154. Krygowska-Wajs A, Wszolek ZK, Uitti RJ, Slowinski J, Szczudlik A. [The current therapies for parkinson's disease. Part I: pharmacological treatment]. Neurol Neurochir Pol. 2003 May-Jun; 37(3):665-76.
    View PubMed
  155. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, Parkinson Study Group. Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet. 2003 Apr; 72(4):1053-7. Epub 2003 Mar 13.
    View PubMed
  156. Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Marder K, Conneally PM, Nichols WC, Parkinson Study Group. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology. 2003 Mar 11; 60(5):796-801.
    View PubMed
  157. Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T, Parkinson Study Group. Reliability of reported age at onset for Parkinson's disease. Mov Disord. 2003 Mar; 18(3):275-9.
    View PubMed
  158. Krygowska-Wajs A, Hussey JM, Hulihan M, Farrer MJ, Tsuboi Y, Uitti RJ, Wszolek ZK. Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci. Parkinsonism Relat Disord. 2003 Mar; 9(4):193-200.
    View PubMed
  159. Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML. Hereditary tauopathies and parkinsonism. Adv Neurol. 2003; 91:153-63.
    View PubMed
  160. Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, Soulages X, Murrell JR, Ghetti B, Yasuda M, Komure O, Kuno S, Arima K, Sunohara N, Kobayashi T, Mizuno Y, Wszolek ZK. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology. 2002 Dec 10; 59(11):1791-3.
    View PubMed
  161. Uitti RJ, Tsuboi Y, Pooley RA, Putzke JD, Turk MF, Wszolek ZK, Witte RJ, Wharen RE. Magnetic resonance imaging and deep brain stimulation. Neurosurgery. 2002 Dec; 51(6):1423-8.
    View PubMed
  162. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, Parkinson Study Group. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet. 2002 Jul; 71(1):124-35. Epub 2002 Jun 07.
    View PubMed
  163. Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. Arch Neurol. 2002 Jun; 59(6):943-50.
    View PubMed
  164. Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol. 2002 Apr; 103(4):344-50. Epub 2001 Dec 08.
    View PubMed
  165. Pal PK, Wszolek ZK, Uitti R, Markopoulou K, Calne SM, Stoessl AJ, Calne DB. Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes. Parkinsonism Relat Disord. 2001 Sep; 8(1):51-6.
    View PubMed
  166. Pal PK, Wszolek ZK, Kishore A, de la Fuente-Fernandez R, Sossi V, Uitti RJ, Dobko T, Stoessl AJ. Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene). Parkinsonism Relat Disord. 2001 Apr; 7(2):81-8.
    View PubMed
  167. Obwegeser AA, Uitti RJ, Witte RJ, Lucas JA, Turk MF, Wharen RE Jr. Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors. Neurosurgery. 2001 Feb; 48(2):274-81; discussion 281-4.
    View PubMed
  168. Obwegeser AA, Uitti RJ, Turk MF, Wszolek UM, Flipse TR, Smallridge RC, Witte RJ, Wharen RE Jr. Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator. Mayo Clin Proc. 2001 Jan; 76(1):87-9.
    View PubMed
  169. Wszolek ZK, Uitti RJ, Markopoulou K. Familial Parkinson's disease and related conditions - Clinical genetics. Adv Neurol. 2001; (86):33-43.
    View PubMed
  170. Obwegeser AA, Uitti RJ, Lucas JA, Witte RJ, Turk MF, Wharen RE Jr. Predictors of neuropsychological outcome in patients following microelectrode-guided pallidotomy for Parkinson's disease. J Neurosurg. 2000 Sep; 93(3):410-20.
    View PubMed
  171. Uitti RJ, Wharen RE, Duffy JR, Lucas JA, Schneider SL, Rippeth JD, Wszolek ZK, Obwegeser AA, Turk MF, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: speech, motor, and neuropsychological outcome measurements. Parkinsonism Relat Disord. 2000 Jul 1; 6(3):133-43.
    View PubMed
  172. Obwegeser AA, Uitti RJ, Turk MF, Strongosky AJ, Wharen RE. Thalamic stimulation for the treatment of midline tremors in essential tremor patients. Neurology. 2000 Jun 27; 54(12):2342-4.
    View PubMed
  173. Lucas JA, Rippeth JD, Uitti RJ, Shuster EA, Wharen RE. Neuropsychological functioning in a patient with essential tremor with and without bilateral VIM stimulation. Brain Cogn. 2000 Mar; 42(2):253-67.
    View PubMed
  174. Uitti RJ. Surgical treatments for Parkinson's disease. Can Fam Physician. 2000 Feb; 46:368-73.
    View PubMed
  175. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord. 1999 Nov; 14(6):940-6.
    View PubMed
  176. Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J, Sima A, D'Amato C, Albin R, Gilman S, Yen SH. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol. 1999 Oct; 155(4):1241-51.
    View PubMed
  177. Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol. 1999 Sep; 56(9):1152-5.
    View PubMed
  178. Jarman PR, del Grosso N, Valente EM, Leube B, Cassetta E, Bentivoglio AR, Waddy HM, Uitti RJ, Maraganore DM, Albanese A, Frontali M, Auburger G, Bressman SB, Wood NW, Nygaard TG. Primary torsion dystonia: the search for genes is not over. Journal of Neurology, Neurosurgery & Psychiatry. 1999 Sep; 67(3):395-7.
    View PubMed
  179. Uitti RJ, Wszolek ZK. Medical treatment of Parkinson's disease. Neurosci News. 1999; 2(3-4):36-43.
  180. Wszolek ZK, Uitti RJ. The clinical genetics of Parkinson's disease. Neurosci News. 1999; 2(3-4):66-72.
  181. Bronstein JM, DeSalles A, DeLong MR, Uitti RJ, et al. Stereotactic pallidotomy in the treatment of Parkinson's disease. Archives of Neurology. 1999; 56:1064-9.
    View PubMed
  182. Uitti RJ, Wharen RE Jr, Turk MF. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease. Neurology. 1998 Dec; 51(6):1755-7.
    View PubMed
  183. Uitti RJ, Turk MF. Treatment of movement disorders in the home care setting. Home Healthcare Consultant. 1998 Oct; 5(10):13-6, 19-22.
  184. Uitti RJ. Tremor: how to determine if the patient has Parkinson's disease. Geriatrics. 1998 May; 53(5):30-6.
    View PubMed
  185. Uitti RJ. Medical treatment of essential tremor and Parkinson's disease. Geriatrics. 1998 May; 53(5):46-8, 53-7.
    View PubMed
  186. Finton MJ, Lucas JA, Graff-Radford NR, Uitti RJ. Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease. J Clin Exp Neuropsychol. 1998 Apr; 20(2):186-93.
    View PubMed
  187. Rajrut AH, Uitti RJ, Fenton ME, George D. Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord. 1997 Dec; 3(4):211-4.
    View PubMed
  188. Rajput AH, Uitti RJ, Rajput AH, Offord KP. Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat Disord. 1997 Nov; 3(3):159-65.
    View PubMed
  189. Wszolek ZK, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, Berry K, Calne DB, Vingerhoets FJ, Klein C, Pfeiffer RF. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord. 1997 Nov; 3(3):125-39.
    View PubMed
  190. Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology. 1997 Oct; 49(4):1072-7.
    View PubMed
  191. Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin Proc. 1997 Jun; 72(6):495-504.
    View PubMed
  192. Shinotoh H, Vingerhoets FJ, Lee CS, Uitti RJ, Schulzer M, Calne DB, Tsui J. Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study. Neurology. 1997 May; 48(5):1282-5.
    View PubMed
  193. Uitti RJ, Shinotoh H, Hayward M, Schulzer M, Mak E, Calne DB. "Familial Parkinson's disease"--a case-control study of families. Can J Neurol Sci. 1997 May; 24(2):127-32.
    View PubMed
  194. Uitti RJ, Vingerhoets FJ, Hayward M, Cooper S, Snow BJ. Positron emission tomography (PET) measurements of striatal D(2) receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months' treatment with SINEMET((R)) or SINEMET((R)) CR. Parkinsonism Relat Disord. 1997 Jan; 3(1):43-6.
    View PubMed
  195. Bressman SB, Warner TT, Almasy L, Uitti RJ, Greene PE, Heiman GA, Raymond D, Ford B, de Leon D, Fahn S, Kramer PL, Risch NJ, Maraganore DM, Nygaard TG, Harding AE. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol. 1996 Oct; 40(4):681-4.
    View PubMed
  196. Di Paola R, Uitti RJ. Early detection of Parkinson's disease. Implications for treatment. Drugs Aging. 1996 Sep; 9(3):159-68.
    View PubMed
  197. Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology. 1996 Jun; 46(6):1551-6.
    View PubMed
  198. Uitti RJ, Ahlskog JE. Comparative review of dopamine receptor agonists in Parkinson's disease. CNS Drugs. 1996 May; 5(5):369-388.
  199. Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E. Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases. J Neurol Sci. 1996 Mar; 136(1-2):162-8.
    View PubMed
  200. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology. 1996 Mar; 46(3):796-801.
    View PubMed
  201. Uitti RJ, Turk MF. Diagnosis and treatment of common movement disorders in nursing home residents. Nursing Home Medicine. 1996; 4:149-160.
  202. Gasser T, Wszolek Z, Supala A, Trofatter J, Ozelius L, Uitti RJ, Pfeiffer RF, Gusella J, Calne D, Breakefield XO. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes. Adv Neurol. 1996; 69:87-95.
    View PubMed
  203. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord. 1995 Sep; 10(5):566-73.
    View PubMed
  204. Uitti RJ, Berry K, Yasuhara O, Eisen A, Feldman H, McGeer PL, Calne DB. Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease. Parkinsonism Relat Disord. 1995 Jul; 1(1):21-34.
    View PubMed
  205. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology. 1995 Mar; 45(3 Pt 1):502-5.
    View PubMed
  206. Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease. Neurology. 1995 Mar; 45(3 Pt 1):443-7.
    View PubMed
  207. Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol. 1994 Sep; 36(3):387-96.
    View PubMed
  208. Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB. Parkinsonism induced by solvent abuse. Ann Neurol. 1994 May; 35(5):616-9.
    View PubMed
  209. Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology. 1993 Oct; 43(10):1918-26.
    View PubMed
  210. Uitti RJ, Maraganore DM. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord. 1993 Oct; 8(4):489-94.
    View PubMed
  211. Uitti RJ, Calne DB. Pathogenesis of idiopathic parkinsonism. Eur Neurol. 1993; 33(Suppl 1):6-23.
    View PubMed
  212. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989 Oct; 12(5):375-83.
    View PubMed
  213. Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK. Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains. Can J Neurol Sci. 1989 Aug; 16(3):310-4.
    View PubMed
  214. Desai HB, Rajput AH, Uitti RJ. Recurrent spinal cord ischemia due to abdominal aortic aneurysm--a case report. Angiology. 1989 Jul; 40(7):682-7.
    View PubMed
  215. Rajput AH, Uitti RJ, Sudhakar S, Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol. 1989 Jun; 25(6):602-6.
    View PubMed
  216. Uitti RJ, Donat JR, Rozdilsky B, Schneider RJ, Koeppen AH. Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol. 1988 Oct; 45(10):1118-22.
    View PubMed
  217. Munoz DG, Ha T, Uitti RJ. Neurite extension on dibutyryl cyclic AMP-stimulated astrocytes. Exp Neurol. 1988 Sep; 101(3):374-84.
    View PubMed
  218. Rajput AH, Uitti RJ, Rajput AH. Neurological disorders and services in Saskatchewan--a report based on provincial health care records. Neuroepidemiology. 1988; 7(3):145-51.
    View PubMed
  219. Calne S, Schoenberg B, Martin W, Uitti RJ, Spencer P, Calne DB. Familial Parkinson's disease: possible role of environmental factors. Can J Neurol Sci. 1987 Aug; 14(3):303-5.
    View PubMed
  220. Rajput AH, Uitti RJ, Stern W, Laverty W, O'Donnell K, O'Donnell D, Yuen WK, Dua A. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can J Neurol Sci. 1987 Aug; 14(3 Suppl):414-8.
    View PubMed
  221. Uitti RJ, Rajput AH, Rozdilsky B, Yuen WK. Regional distribution of metals in human brain. Clin Invest Med. 1987 Jan; 10(1):10-3.
    View PubMed
  222. Uitti RJ, Rajput AH. Diagnosis and treatment of Parkinson's disease and tremor. CME News. 1987; 17:6-7.
  223. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson's disease and childhood environment. Adv Neurol. 1987; 45:295-7.
    View PubMed
  224. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson's disease in Saskatchewan--environmental considerations for etiology. Can J Neurol Sci. 1986 Nov; 13(4):312-6.
    View PubMed
  225. Uitti RJ, Rajput AH. Multiple sclerosis presenting as isolated oculomotor nerve palsy. Can J Neurol Sci. 1986 Aug; 13(3):270-2.
    View PubMed
  226. Uitti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B. Cyanide-induced parkinsonism: a clinicopathologic report. Neurology. 1985 Jun; 35(6):921-5.
    View PubMed